INmune Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.

CEO

Raymond J. Tesi

CEORaymond J. Tesi

Employees

Employees22

Headquarters

Boca Raton, Florida

HeadquartersBoca Raton, Florida

Founded

2015

Founded2015

Employees

Employees22

INMB Key Statistics

Market cap

188.95M

Market cap188.95M

Price-Earnings ratio

-3.87

Price-Earnings ratio-3.87

Dividend yield

—

Dividend yield—

Average volume

289.00K

Average volume289.00K

High today

$8.67

High today$8.67

Low today

$8.01

Low today$8.01

Open price

$8.03

Open price$8.03

Volume

294.60K

Volume294.60K

52 Week high

$12.72

52 Week high$12.72

52 Week low

$4.32

52 Week low$4.32

INmune Bio

Why Robinhood?

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. Show more

INMB Key Statistics

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.